Eutilex.Co.Ltd (263050) - Total Liabilities

Latest as of September 2025: ₩22.09 Billion KRW ≈ $14.97 Million USD

Based on the latest financial reports, Eutilex.Co.Ltd (263050) has total liabilities worth ₩22.09 Billion KRW (≈ $14.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Eutilex.Co.Ltd (263050) cash conversion ratio to assess how effectively this company generates cash.

Eutilex.Co.Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Eutilex.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Eutilex.Co.Ltd (263050) asset resilience to evaluate the company's liquid asset resilience ratio.

Eutilex.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Eutilex.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kalyani Forge Limited NSE:KALYANIFRG	India	Rs1.67 Billion
JPMorgan American Investment Trust LSE:JAM	UK	GBX102.83 Million
Korea SE Corp KQ:101670	Korea	₩16.53 Billion
Conduril - Engenharia S.A LS:CDU	Portugal	€157.89 Million
Hermana Holding ASA OL:HERMA	Norway	Nkr200.00K
SCGM Bhd KLSE:7247	Malaysia	RM731.00K
Brilliant Earth Group Inc NASDAQ:BRLT	USA	$121.27 Million
Republic Power Group Limited Class A Ordinary Shares NASDAQ:RPGL	USA	$3.70 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Eutilex.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Eutilex.Co.Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.83	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eutilex.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual total liabilities of Eutilex.Co.Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.57 Billion ≈ $18.01 Million	+116.66%
2023-12-31	₩12.26 Billion ≈ $8.31 Million	-26.62%
2022-12-31	₩16.71 Billion ≈ $11.33 Million	-63.11%
2021-12-31	₩45.31 Billion ≈ $30.70 Million	-3.64%
2020-12-31	₩47.02 Billion ≈ $31.87 Million	+256.70%
2019-12-31	₩13.18 Billion ≈ $8.93 Million	+74.17%
2018-12-31	₩7.57 Billion ≈ $5.13 Million	+2.88%
2017-12-31	₩7.36 Billion ≈ $4.99 Million	+29.42%
2016-12-31	₩5.68 Billion ≈ $3.85 Million	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24464 Global

#1805 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩2740.00

All Time High

₩41553.86